Overall Technical outlook

Price Summary

The stock of Piramal Pharma Limited experienced a 3.5% jump, showcasing a outstanding market performance.
On 2025-07-15, Piramal Pharma Limited's stock began at 208.9, peaked at 217.9, bottomed at 208.89, and closed 3.5% higher at 216.22, with a volume of 18358067 shares.
The stock reached its highest price of 293.55 and its lowest price of 147.9 during the 52-week period.
10 analysts forecast that the price of PPLPHARMA will range from 230.0 to 320.0, with an average expected price near 267.5.

Technicals

Support and Resistance: At 216.22, the price for PPLPHARMA is supported at 201.82 and resisted at 218.79. This indicates a trading range where 201.82 serves as a support level, potentially preventing further decline, while 218.79 could limit upward movement.
PPLPHARMA supportResistance 4e6479
Support/Resistance for PPLPHARMA


Aroon: The bullish trend indicated by Aroon persists, with Aroon Up holding at the 100 level for PPLPHARMA. This shows strong upward momentum, but further analysis using additional indicators is necessary to determine the trend's sustainability and future potential.
PPLPHARMA aroon 4e6479
Aroon chart for Piramal Pharma Limited


Bol. Bands: The current price has recently moved above the upper Bollinger Band, marking a bullish signal. This breakout indicates that the market is experiencing heightened buying interest, pushing prices for PPLPHARMA beyond their usual range. Such a move is often viewed as a sign of increasing momentum, with the potential for further price gains.
PPLPHARMA bbands 4e6479
Bolinger Bands chart for Piramal Pharma Limited


Parabolic SAR: The PSAR continues its bullish outlook, establishing a support level that could help sustain the current upward trend. This level of support may act as a cushion against potential downturns, indicating continued strength in the market's bullish momentum for PPLPHARMA.
PPLPHARMA psar 4e6479
Parabolic Stop and Reverse chart for Piramal Pharma Limited


Stochastic: The STOCHASTIC is showing a neutral stance, not indicating a clear upward or downward trend for Piramal Pharma Limited. This suggests a period of market balance, where neither side is showing dominance.
PPLPHARMA stoch 4e6479
Stochastic chart for Piramal Pharma Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
PPLPHARMA trippleSMA 4e6479
Tripple SMA chart for Piramal Pharma Limited


When evaluating a company's technical indicators like price trends and trading volume, it's important to also assess its fundamentals. Key factors include the company's profitability, growth rate, and financial stability. Furthermore, considering the industry within which the company operates provides additional context, as factors like competition and market demand can affect performance. By combining this analysis, you can make more informed judgments about the company's future prospects.